Pioglitazone: The future

International Journal of Clinical Practice

Volumn , Issue , 2001, Pages 36-

  Brunetti, P ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; PIOGLITAZONE; THIAZOLE DERIVATIVE;

CLINICAL TRIAL; DIABETIC ANGIOPATHY; FORECASTING; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FORECASTING; HUMANS; HYPOGLYCEMIC AGENTS; THIAZOLES; THIAZOLIDINEDIONES;

EID: 33749205939     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Hanefeld M. Pharmacokinetics and clinical efficacy of pioglitazone. Int J Clin Pract 2001; Suppl 121: 19-25.
2. Hanefeld M, Belcher G. Safety profile of pioglitazone. Int J Clin Pract 2001 ; Suppl 121: 27-31.
3. Smith U. Pioglitazone: mechanism of action. Int J Clin Pract 2001; Suppl 121:13-18.